Streetbeat News

Regulatory

ALLG

Allego (NYSE:ALLG) has announced the completion of its voluntary delisting from the NYSE, with August 22, 2024, being the last trading day for its shares. The company remains committed to promoting EV adoption in Europe.

Portfolio Pulse from Benzinga Newsdesk

August 22, 2024 | 1:31 pm

GVH

Globavend Holdings has received a notice from Nasdaq for non-compliance with the $1.00 minimum bid price requirement. The company has until February 12, 2025, to regain compliance, and its ordinary shares will continue trading on the Nasdaq Capital Market.

Portfolio Pulse from Benzinga Newsdesk

August 22, 2024 | 1:16 pm

USDTUSD

Tether Holdings Ltd., a major stablecoin issuer, now holds $81 billion in U.S. Treasury bills, marking a significant presence in the Treasury market. This move is seen as a step towards better relations with the U.S. government and financial stability. Despite skepticism, Tether aims to become the largest holder of T-bills, supported by its partnership with Cantor Fitzgerald LP.

Portfolio Pulse from Murtuza Merchant

August 22, 2024 | 1:09 pm

SPY

In a CNBC interview, Fed's Schmid suggested the potential to accelerate the reduction of the Federal Reserve's balance sheet. This could impact market liquidity and interest rates, influencing investor sentiment and stock prices.

Portfolio Pulse from Benzinga Newsdesk

August 22, 2024 | 1:08 pm

CVKD

Cadrenal Therapeutics is set to have a Type-B meeting with the FDA in September to discuss the development of tecarfarin for LVAD patients. This meeting is a significant step towards their pivotal trial.

Portfolio Pulse from Benzinga Newsdesk

August 22, 2024 | 1:04 pm

CVX

Chevron Corporation has been awarded a greenhouse gas assessment permit offshore Western Australia, enhancing its carbon capture and storage portfolio. This aligns with Chevron's strategy to deliver lower carbon energy.

Portfolio Pulse from Benzinga Newsdesk

August 22, 2024 | 1:03 pm

AZTR

Azitra, Inc. has received FDA clearance for a Phase 1/2 clinical study of ATR-04, targeting skin rash from EGFR inhibitors. This condition affects 150,000 patients in the US, representing a market size of over $1 billion. Preclinical data shows ATR-04's potential in reducing key rash drivers.

Portfolio Pulse from Benzinga Newsdesk

August 22, 2024 | 1:01 pm

MSOS

MSOX

The cannabis market is facing volatility, with ETFs like AdvisorShares Pure US Cannabis ETF (MSOS) and its leveraged counterpart MSOX experiencing challenges due to regulatory uncertainty and underperforming stocks. However, potential regulatory reforms, such as cannabis rescheduling, offer hope for recovery.

Portfolio Pulse from Javier Hasse

August 22, 2024 | 1:00 pm

SCHW

TD

TD CEO Masrani acknowledged serious anti-money laundering failures and stated the bank's commitment to maintaining at least a 10% stake in Charles Schwab.

Portfolio Pulse from Benzinga Newsdesk

August 22, 2024 | 12:56 pm

SPY

Federal Reserve's Collins indicates that future rate cuts will be guided by data, with current inflation data suggesting increased confidence in returning to a 2% target.

Portfolio Pulse from Benzinga Newsdesk

August 22, 2024 | 12:54 pm